InsidersTradesSigma
Genocea Biosciences, INC. Stock: price and insider trades · United States · SEC (Form 4)
Track the Genocea Biosciences, INC. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, Genocea Biosciences, INC. has published 30 public disclosures. Market capitalisation: €587. The latest transaction was filed on 3 June 2022 (Cession). Among the most active insiders: Flechtner Jessica Baker. All data is accessible without an account.
30
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€3m
23 ops.
Sell Volume
56Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 June 2022
Declarations30 total
1,578 shares@ US$0.0615.00% mcap3.1% of flowCommon StockSEC:0001457612-22-000074:0
4,023 shares@ US$0.0638.25% mcap2.0% of flowCommon StockSEC:0001457612-22-000073:0
1,355 shares@ US$0.0612.88% mcap2.6% of flowCommon StockSEC:0001457612-22-000075:0
117,244 shares@ US$0.061758.9% of flowCommon StockSEC:0001457612-22-000069:0
2,500 shares@ US$0.060124.02% mcap100.0% of flowCommon StockSEC:0001457612-22-000070:0
20,425 shares@ US$0.0653100.0% of flowCommon StockSEC:0001457612-22-000066:0
5,931,843 shares@ US$0.0654100.0% of flowCommon StockSEC:0001209191-22-032323:0
5,931,843 shares@ US$0.0654100.0% of flowCommon StockSEC:0001209191-22-032326:0
5,931,843 shares@ US$0.0654100.0% of flowCommon StockSEC:0001209191-22-032329:0
5,931,843 shares@ US$0.0654100.0% of flowCommon StockSEC:0001209191-22-032320:0
5,931,843 shares@ US$0.0654100.0% of flowCommon StockSEC:0001209191-22-032331:0
5,931,843 shares@ US$0.0654100.0% of flowCommon StockSEC:0001209191-22-032330:0
24,407 shares@ US$0.076559.7% of flowCommon StockSEC:0001457612-22-000060:0
5,931,843 shares@ US$0.0654100.0% of flowCommon StockSEC:0001209191-22-032317:0
2,500 shares@ US$0.08935.47% mcap100.0% of flowCommon StockSEC:0001457612-22-000062:0
5,931,843 shares@ US$0.0654100.0% of flowCommon StockSEC:0001209191-22-032327:0
16,525 shares@ US$0.088148.1% of flowCommon StockSEC:0001457612-22-000061:0
5,931,843 shares@ US$0.0654100.0% of flowCommon StockSEC:0001209191-22-032322:0
3,924 shares@ US$1.2539.1% of flowCommon StockSEC:0001457612-22-000043:0
963 shares@ US$1.25100.0% of flowCommon StockSEC:0001457612-22-000042:0
963 shares@ US$1.2537.7% of flowCommon StockSEC:0001457612-22-000045:0
1,091 shares@ US$1.25100.0% of flowCommon StockSEC:0001457612-22-000044:0
1,212 shares@ US$1.2548.8% of flowCommon StockSEC:0001457612-22-000046:0
43,750 shares0Common StockSEC:0001457612-22-000034:0
150,000 shares0Common StockSEC:0001457612-22-000026:0
25 of 30 declarations
About Genocea Biosciences, INC.
GENOCEA BIOSCIENCES, INC. is a biotechnology company focused on developing immunotherapies for infectious diseases and cancer. The company utilizes its vaccine discovery platform to identify unique immune targets.